Global Oncology Drugs Market Size, Share, Trends, Growth, Analysis and Forecast 2014-2020: Big Market Research

PORTLAND, Oregon, March 25, 2015 /PRNewswire/ --

Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types, especially for blood cancer (leukemia). Rising incidence of various cancer conditions, growing popularity of advance therapies (biological and targeted drug therapies), patents expiration of leading drugs along with commercialization of biosimilars are the few factors driving the growth of global oncology drugs market. However, high cost involved in new drug development coupled with threat of failure and adverse effects associated with cancer drugs therapies would restrain the growth of the market. Commercialization of advanced therapeutics such as targeted and immunotherapies would reduce the negative influence of restraints and fuel the market growth.

     (Logo: http://photos.prnewswire.com/prnh/20141014/710132)

The global oncology drugs market is expected to reach at $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020. Going further, the biological therapies are expected to dominate the market by 2020, due to their high efficacy, target specific action and less toxicity. Blood cancer drugs market was the largest revenue generating segment in 2013 owing to the high cost of drugs (immunotherapies) used for the treatment of blood cancer.

To Get Complete Report Visit @  http://www.bigmarketresearch.com/oncology-cancer-drugs-market

Geographically, North America, dominates the market followed by Europe. North America accounted for about ~38% share in the overall oncology drugs market in 2013 owing to the heavy investments by multinational companies in research and development of cancer drugs, particularly immune therapeutics, favorable reimbursement policies, and high adoption rate of immunotherapies. On the other hand, Asia-Pacific market would grow at the promising CAGR of 8.7% during the forecast period. Such high growth rate is majorly due to increasing awareness towards advanced therapies namely immunotherapies and increase in per capita healthcare spending.

Key companies profiled in the report are Roche diagnostics, Novartis AG, Celgene Corporation, AstraZeneca, Johnson & Johnson, Merck & Co., Eli Lilly & Co. and GlaxoSmithKline. Companies operating in the cancer drugs market focus on several strategies such as collaboration, approval and acquisition.

Key Benefits 

• The report provides the quantitative analysis of the current market and estimations through 2013-2020 that assists in identifying the prevailing market opportunities to capitalize on
• The report helps in understanding the strategies adopted by various companies for gaining market share in the cancer drugs market
• The report provides comprehensive analysis of factors that drive and restrict the growth of the cancer drugs market
• Market conditions of cancer drugs market across all geographic regions are comprehensively analyzed
• Competitive intelligence (of leading manufacturers) helps in understanding the competitive scenario across the geographies
• SWOT analysis of the key market players is provided to illustrate the business strategies adopted by the companies

Enquire About This Report:  http://www.bigmarketresearch.com/report-enquiry/22695

Market Segmentation 

The cancer drugs market is segmented by the therapeutic modalities, cancer types and geography.

Market By Therapeutic Modalities 

• Chemotherapy
• Targeted Therapy
• Immunotherapy (Biologic Therapy)
• Hormonal Therapy
• Others

Market By Cancer Types 

• Blood Cancer
• Breast Cancer
• Gastrointestinal Cancer
• Prostate Cancer
• Respiratory/Lung Cancer
• Skin Cancer
• Other Cancers

Market By Geography 

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • United Kingdom
  • Others
• Asia-Pacific
  • India
  • China
  • Japan
  • Australia
  • Others
• LAMEA
  • GCC (Gulf Corporation Council)
  • Others

Download Sample @  http://www.bigmarketresearch.com/request-sample/22695

Browse Similar Reports:  

Acute Lymphoblastic Lymphoma - Pipeline Review, H1 2015 

Acute Lymphoblastic Lymphoma - Pipeline Review, H1 2015', provides an overview of the Acute Lymphoblastic Lymphoma's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Acute Lymphoblastic Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

To Get Details:  http://www.bigmarketresearch.com/acute-lymphoblastic-lymphoma-pipeline-review-h1-2015-market

Global Telemedicine Market 

Telemedicine overcomes the barrier of distance by providing clinical health care through information technology and telecommunication. It makes health service more accessible, particularly in isolated rural areas where medical care is not consistently available primarily due to the location. Telemedicine enables effective communication between medical staff and patients, and facilitates the transmission of crucial health and medical information.

To Get Details:  http://www.bigmarketresearch.com/telemedicine-market

About Us: 

With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:
Deep Joshi
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
Direct: +1 (617) 674-4143
Toll Free: +1 (855) 711-1555
Fax: +1 (855) 550-5975
Email: [email protected]
Web: http://www.bigmarketresearch.com
Blog: http://www.bigmarketresearch.blogspot.com

SOURCE Big Market Research